Improvement of abnormal hepatic function in chronic hepatic disease. Eczema or dermatitis, urticaria, pruritus, drug eruption or toxicoderma, stomatitis, infant strophulus, phlycten.
IVAdult 5-20 mL once daily, may be adjusted depending on patient's age & symptoms. Chronic hepatic disease 40-60 mL once daily by inj or drip infusion, may be adjusted depending on patient's age & symptoms. Max: 100 mL.
Thoroughly conduct interviews to predict occurrence of shocks. Provide emergency treatments in case shock occurs. Maintain patient at rest & carefully monitor after administration. Co-administration w/ products containing licorice may cause pseudoaldosteronism. Inj as slowly as possible while monitoring the patient. Rhabdomyolysis. Hypokalemia may occur w/ loop diuretics, thiazides & other related anti-hypertensive diuretics. Monitor serum K levels. Ventricular tachycardia (including Torsades de pointes) or prolonged QT may occur w/ moxifloxacin HCl. Pregnant or possibly pregnant patients. Increased rate of hypokalemia in the elderly. Monitor elderly patients during treatment.
Sign Out
